Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
Clinical trial NCT00057616 · COMPLETED
Trial details
- NCT number
- NCT00057616
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.